GSK3 Restrains Germinal Center B Cells to Form Plasma Cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• B cells in germinal centers (GCs) differentiate into plasma cells (PCs) or memory B cells.
• The precise molecular mechanisms governing GC B cell fate decisions remain incompletely understood.

Purpose of the Study:

• To investigate the role of glycogen synthase kinase 3 (GSK3) in regulating GC B cell differentiation.
• To elucidate the molecular pathways through which GSK3 influences B cell fate toward PC formation.

Main Methods:

• Genetic ablation and pharmacological inhibition of GSK3 in mouse GC B cells.
• Analysis of transcription factor expression and B cell properties following GSK3 manipulation.
• Stimulation with CD40L and IL-21 to mimic T cell-dependent B cell activation.

Main Results:

• GSK3 inhibition in GC B cells promoted differentiation into PCs and acquisition of dark zone characteristics.
• GSK3 inactivation synergistically upregulated transcription factors Foxo1 and c-Myc under CD40L and IL-21 stimulation.
• This led to increased levels of IRF4, a key transcription factor for PC differentiation.

Conclusions:

• GSK3 acts as an upstream regulator controlling external cue interpretation in GC B cells.
• GSK3-mediated modulation of transcription factors facilitates dark zone transition and PC fate commitment.
• Targeting GSK3 offers a potential strategy for manipulating B cell differentiation pathways.